These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19587541)

  • 1. HPV E6 oncoprotein prevents recovery of stalled replication forks independently of p53 degradation.
    Day T; Vaziri C
    Cell Cycle; 2009 Jul; 8(14):2138. PubMed ID: 19587541
    [No Abstract]   [Full Text] [Related]  

  • 2. Human papilloma virus type16 E6 deregulates CHK1 and sensitizes human fibroblasts to environmental carcinogens independently of its effect on p53.
    Chen B; Simpson DA; Zhou Y; Mitra A; Mitchell DL; Cordeiro-Stone M; Kaufmann WK
    Cell Cycle; 2009 Jun; 8(11):1775-87. PubMed ID: 19411857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus E6 regulates the cytoskeleton dynamics of keratinocytes through targeted degradation of p53.
    Cooper B; Brimer N; Vande Pol SB
    J Virol; 2007 Nov; 81(22):12675-9. PubMed ID: 17804489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.
    Martinez-Zapien D; Ruiz FX; Poirson J; Mitschler A; Ramirez J; Forster A; Cousido-Siah A; Masson M; Vande Pol S; Podjarny A; Travé G; Zanier K
    Nature; 2016 Jan; 529(7587):541-5. PubMed ID: 26789255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.
    Scheffner M; Huibregtse JM; Vierstra RD; Howley PM
    Cell; 1993 Nov; 75(3):495-505. PubMed ID: 8221889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.
    Conrady MC; Suarez I; Gogl G; Frecot DI; Bonhoure A; Kostmann C; Cousido-Siah A; Mitschler A; Lim J; Masson M; Iftner T; Stubenrauch F; Travé G; Simon C
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
    Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
    J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HPV16 E6 oncoprotein and UVB irradiation inhibit the tumor suppressor TGFβ pathway in the epidermis of the K14E6 transgenic mouse.
    Popoca-Cuaya M; Diaz-Chavez J; Hernandez-Monge J; Alvarez-Rios E; Lambert PF; Gariglio P
    Exp Dermatol; 2015 Jun; 24(6):430-5. PubMed ID: 25776923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex.
    Gewin L; Myers H; Kiyono T; Galloway DA
    Genes Dev; 2004 Sep; 18(18):2269-82. PubMed ID: 15371341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent.
    Tomaić V; Pim D; Banks L
    Virology; 2009 Oct; 393(1):7-10. PubMed ID: 19700180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CIP2A facilitates the G1/S cell cycle transition via B-Myb in human papillomavirus 16 oncoprotein E6-expressing cells.
    Tian Y; Chen H; Qiao L; Zhang W; Zheng J; Zhao W; Chen JJ; Zhang W
    J Cell Mol Med; 2018 Sep; 22(9):4150-4160. PubMed ID: 29893470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
    Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
    Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoexpression of mutant p53 and human papillomavirus related E6 oncoprotein in anal malignancies.
    Gupta S; Sharma BK
    Indian J Exp Biol; 1998 Sep; 36(9):875-8. PubMed ID: 9854426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation.
    Alarcón R; Koumenis C; Geyer RK; Maki CG; Giaccia AJ
    Cancer Res; 1999 Dec; 59(24):6046-51. PubMed ID: 10626788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients.
    Chen SP; Hsu NY; Wu JY; Chen CY; Chou MC; Lee H; Cheng YW
    Ann Thorac Surg; 2013 Apr; 95(4):1196-203. PubMed ID: 23522190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical co-expression of human papillomavirus type 16/18 transforming (E6) oncoprotein and p53 tumour suppressor gene proteins in oesophageal cancer.
    Agarwal SK; Chatterji A; Bhambhani S; Sharma BK
    Indian J Exp Biol; 1998 Jun; 36(6):559-63. PubMed ID: 9731468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.
    Stutz C; Reinz E; Honegger A; Bulkescher J; Schweizer J; Zanier K; Travé G; Lohrey C; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS One; 2015; 10(7):e0132339. PubMed ID: 26151636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation.
    Li X; Coffino P
    J Virol; 1996 Jul; 70(7):4509-16. PubMed ID: 8676476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
    Kessis TD; Slebos RJ; Nelson WG; Kastan MB; Plunkett BS; Han SM; Lorincz AT; Hedrick L; Cho KR
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3988-92. PubMed ID: 8387205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins.
    Scheffner M; Takahashi T; Huibregtse JM; Minna JD; Howley PM
    J Virol; 1992 Aug; 66(8):5100-5. PubMed ID: 1321290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.